Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

IIONIS PHARMACEUTICALS INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
I

IONIS PHARMACEUTICALS INC

$45.75Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $267.95M. Net result −$114.65M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $267.95M. Running result $267.95M. Collaborative Agreement Revenue: $133.14M. DAWNZERA Sales: $26.57M. Other Commercial: $11.53M. Other Royalties: $6.04M. Spinraza Royalties: $53.49M. Tryngolza: $4.57M. Wainua Joint Development Revenue: $16.19M. Wainus Royalties: $16.44M.
  • Cost of revenue: −$2.74M. Running result $265.21M.
  • Gross profit: $265.21M. Running result $265.21M.
  • Research, development and patent: −$217.11M. Running result $48.1M.
  • Selling, general and administrative: −$150.4M. Running result −$102.29M.
  • Operating income: −$102.29M. Running result −$102.29M.
  • Other expense: −$11.09M. Running result −$113.38M.
  • Pre-tax loss: −$113.38M. Running result −$113.38M.
  • Income tax expense: −$1.26M. Running result −$114.65M.
  • Net loss: −$114.65M. Running result −$114.65M.